These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 27557490)
1. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study. Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490 [TBL] [Abstract][Full Text] [Related]
2. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3. Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042 [TBL] [Abstract][Full Text] [Related]
3. Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer. Zhang X; Hua R; Wang X; Huang M; Gan L; Wu Z; Zhang J; Wang H; Cheng Y; Li J; Guo W Oncotarget; 2016 Mar; 7(9):9815-31. PubMed ID: 26769843 [TBL] [Abstract][Full Text] [Related]
4. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer. You L; Guo X; Huang Y Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related]
6. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells]. Yan ZY; Sun XC Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669 [No Abstract] [Full Text] [Related]
7. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373 [TBL] [Abstract][Full Text] [Related]
8. Relationship between epithelial cell adhesion molecule (EpCAM) overexpression and gastric cancer patients: A systematic review and meta-analysis. Dai M; Yuan F; Fu C; Shen G; Hu S; Shen G PLoS One; 2017; 12(4):e0175357. PubMed ID: 28403178 [TBL] [Abstract][Full Text] [Related]
10. High expression of octamer-binding transcription factor 4A, prominin-1 and aldehyde dehydrogenase strongly indicates involvement in the initiation of lung adenocarcinoma resulting in shorter disease-free intervals. Cortes-Dericks L; Galetta D; Spaggiari L; Schmid RA; Karoubi G Eur J Cardiothorac Surg; 2012 Jun; 41(6):e173-81. PubMed ID: 22529186 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of CD13 and stem cell markers in CD133-induced liver cancer in mice. Wang Q; Chen N; Yu C; Wei Z; Li Z; Jin Z J BUON; 2019; 24(4):1408-1413. PubMed ID: 31646784 [TBL] [Abstract][Full Text] [Related]
12. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression. Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876 [TBL] [Abstract][Full Text] [Related]
13. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. Tsunedomi R; Yoshimura K; Suzuki N; Hazama S; Nagano H Surg Today; 2020 Dec; 50(12):1560-1577. PubMed ID: 32025858 [TBL] [Abstract][Full Text] [Related]
14. Co-Expression of LGR5 and CD133 Cancer Stem Cell Predicts a Poor Prognosis in Patients With Gastric Cancer. Wattanawongdon W; Bathpho TS; Tongtawee T Turk J Gastroenterol; 2021 Mar; 32(3):261-268. PubMed ID: 34160355 [TBL] [Abstract][Full Text] [Related]
15. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Stanisavljević L; Myklebust MP; Leh S; Dahl O Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662 [TBL] [Abstract][Full Text] [Related]
17. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E Cells; 2020 May; 9(5):. PubMed ID: 32408542 [TBL] [Abstract][Full Text] [Related]
18. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer. Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144 [TBL] [Abstract][Full Text] [Related]
19. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer. Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827 [TBL] [Abstract][Full Text] [Related]
20. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival. El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]